Global Animal Internal Dewormer Market Size By Type (Tablet, Powder), By Application (Livestock, Pets), By Region, And Segment Forecasts, 2023 to 2032

The Global Animal Internal Dewormer Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.4 billion by 2031, growing at a CAGR of 7.3% during the forecast period of 2023 to 2031. The increasing prevalence of parasitic infections in livestock and companion animals, combined with the rising demand for safe and high-quality animal products, is fueling market growth. Internal dewormers, also known as anthelmintics, are critical in veterinary care, helping maintain animal health, improving productivity, and minimizing zoonotic transmission risks. The market is experiencing additional momentum from growing veterinary healthcare investments, increased awareness about animal health management, and improved access to veterinary services, especially in developing regions.

Drivers:

1. Rising Incidence of Parasitic Infections:

Internal parasites continue to pose a serious threat to livestock and pets globally. The need to control worm infestations to prevent productivity losses and animal deaths is driving the demand for internal deworming solutions.

2. Growing Awareness of Animal Health:

Government and non-governmental initiatives advocating better livestock management and pet care are creating strong demand for preventive veterinary care, including regular deworming schedules.

3. Expansion of the Livestock Industry:

The growing global population and rising demand for meat, dairy, and poultry are expanding the livestock sector, which in turn propels the use of internal dewormers to maintain herd health and ensure optimal productivity.

Restraints:

1. Anthelmintic Resistance:

Frequent and improper use of dewormers has led to the development of drug-resistant parasite strains. This resistance reduces treatment efficacy and complicates parasite control strategies.

2. Stringent Regulatory Approval Processes:

The development and approval of veterinary pharmaceuticals, including internal dewormers, are governed by strict regulations, which may hinder new product launches and limit smaller companies' participation.

Opportunity:

1. Demand for Natural and Organic Dewormers:

As consumers show increased preference for organically raised animal products, there's a surge in demand for natural internal dewormers made from herbal or botanical sources.

2. Growth in Companion Animal Ownership:

The rising trend of pet adoption, particularly in urban regions, is expected to provide substantial growth opportunities for internal dewormers designed for cats, dogs, and exotic animals.

3. Penetration into Emerging Markets:

Emerging economies in Asia-Pacific, Latin America, and Africa are investing in modern veterinary infrastructure and livestock healthcare, offering significant market expansion potential.

Market by System Type Insights:

Based on product/system type, Benzimidazoles held the largest market share in 2023. This class of dewormers is widely used for its broad-spectrum activity, affordability, and ease of administration. However, Macrocyclic Lactones, due to their efficacy against both internal and external parasites, are expected to exhibit the fastest growth rate during the forecast period. Combination dewormers that tackle multiple parasite species are also gaining popularity.

Market by End-use Insights:

The Livestock segment (including cattle, sheep, goats, swine, and poultry) emerged as the dominant end-use category, accounting for over 60% of market revenue in 2023. Internal deworming is essential in livestock management for disease control and productivity improvement. The Companion Animal segment is witnessing significant growth as more pet owners embrace preventive veterinary healthcare.

Market by Regional Insights:

North America led the global market in 2023, thanks to a robust veterinary infrastructure, high awareness levels, and increased spending on pet and livestock care. Asia-Pacific is anticipated to be the fastest-growing region due to expanding livestock populations, rising disposable incomes, and supportive government initiatives promoting animal health. Europe also holds a notable share, driven by stringent food safety regulations and the presence of established veterinary pharmaceutical companies.

Competitive Scenario:

Prominent players in the Global Animal Internal Dewormer Market include Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Inc., Merck Animal Health, Virbac, Vetoquinol S.A., Bayer Animal Health, and Ceva Santé Animale. These companies are focusing on product innovation, expansion in emerging markets, and strategic partnerships.

Recent Developments:

In 2023, Zoetis launched a next-generation chewable dewormer for dogs with dual-action effectiveness.

Merck Animal Health expanded its parasitic control product line through a new injectable dewormer for cattle in 2024.

In 2025, Virbac announced a partnership with an Indian pharmaceutical company to produce cost-effective oral dewormers for emerging markets.

Scope of Work – Global Animal Internal Dewormer Market

Key Market Developments:

2023: Zoetis introduced a novel chewable dewormer targeting both roundworms and hookworms in dogs.

2024: Elanco launched a multi-species dewormer for integrated parasite control across cattle, sheep, and goats.

2025: Merck expanded its product portfolio in Southeast Asia through a joint venture focused on bovine dewormers.

FAQs:

1) What is the current market size of the Global Animal Internal Dewormer Market?

The market was valued at USD 3.1 billion in 2023.

2) What is the major growth driver of the Global Animal Internal Dewormer Market?

The major growth driver is the rising incidence of parasitic infections among livestock and companion animals.

3) Which is the largest region during the forecast period in the Global Animal Internal Dewormer Market?

North America is the largest regional market, while Asia-Pacific is projected to witness the highest growth.

4) Which segment accounted for the largest market share in the Global Animal Internal Dewormer Market?

The Livestock segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Animal Internal Dewormer Market?

Key players include Zoetis Inc., Boehringer Ingelheim, Merck Animal Health, Elanco, and Virbac.